Dual-task gait speed assessments with an electronic walkway and a stopwatch in older adults. A reliability study.
M Montero-Odasso, Y Sarquis-Adamson, N Kamkar...
https://pubmed.ncbi.nlm.nih.gov/33017671/Actively Recruiting
Led by McGill University · Updated on 2026-01-20
1573
Participants Needed
19
Research Sites
317 weeks
Total Duration
Researchers are conducting a long-term observational study involving individuals aged 50 to 90 with various types of dementia, mild cognitive impairments, and a comparison group without cognitive problems. The study includes people with conditions such as Alzheimers Disease, Parkinsons Disease Dementia, Frontotemporal Dementia, and healthy elderly participants without cognitive complaints. The study started with over 1,000 participants across 30 centers in Canada to better understand these conditions and their progression. Participants undergo thorough initial evaluations including clinical and neuropsychological assessments, genomics, neuroimaging, and biological sample collection from blood, saliva, urine, feces, buccal cells, and cerebrospinal fluid. The study follows participants over time with annual check-ins to track changes in diagnosis and cognition. Additional follow-ups occur at two specific time points to observe longer-term changes, with recruitment continuing for certain non-dementia groups at later phases. During the study, participants will complete ongoing clinical and cognitive tests, brain scans, and provide biological samples. Researchers measure cognitive function using tools like the Montreal Cognitive Assessment MoCA over an 8-year period. The study also requires participants to have a study partner to provide additional information. Participation involves yearly re-evaluations to monitor health and cognitive status throughout the study duration, which extends up to several years.
CONDITIONS
Comprehensive Assessment of Neurodegeneration and Dementia
H
Howard Chertkow, MD
R
Randi Pilon
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
McGill University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline visit
Participants undergo comprehensive baseline evaluations including clinical and neuropsychological assessments, neuroimaging, and collection of biological samples.
1 visit (in-person)
Duration - Up to 8 years
Participants are followed annually to assess changes in diagnosis with repeated evaluations at specified timepoints.
Annual visits and additional evaluations at two longitudinal re-evaluation timepoints
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Have more questions? Get in touch with our team for quick support
M Montero-Odasso, Y Sarquis-Adamson, N Kamkar...
https://pubmed.ncbi.nlm.nih.gov/33017671/McGill University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor